Business Description
Patrys Ltd
ISIN : AU000000PAB9
Total Employee Number:
23Description
Patrys Ltd is a biopharmaceutical company engaged in the development of a proprietary intravenous (IV) formulation of quetiapine and an antibody platform known as deoxymabs. Its development programs target therapeutic applications in cancer, inflammatory diseases, and other medical conditions. The company's pipeline includes clinical-stage and early-stage research and development programs.
Financial Strength
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | No Debt | |||||
Equity-to-Asset | 0.74 | |||||
Interest Coverage | No Debt | |||||
Piotroski F-Score | 2/9 | |||||
WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year EBITDA Growth Rate | 31 | |||||
3-Year EPS without NRI Growth Rate | 26.9 | |||||
3-Year FCF Growth Rate | 42.3 | |||||
3-Year Book Growth Rate | -62.7 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
9-Day RSI | 100 | |||||
14-Day RSI | 100 | |||||
6-1 Month Momentum % | 50 | |||||
12-1 Month Momentum % | 50 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 3.8 | |||||
Quick Ratio | 3.8 | |||||
Cash Ratio | 3.58 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -4.8 | |||||
Shareholder Yield % | -7.01 |
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
ROE % | -322.66 | |||||
ROA % | -190.33 | |||||
ROIC % | -561.34 | |||||
3-Year ROIIC % | -175.33 | |||||
ROC (Joel Greenblatt) % | -123228.57 | |||||
ROCE % | -308 | |||||
Moat Score | 2 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PB Ratio | 9.75 | |||||
Price-to-Tangible-Book | 9.75 | |||||
EV-to-EBIT | -5.59 | |||||
EV-to-EBITDA | -5.59 | |||||
EV-to-FCF | -10.06 | |||||
Earnings Yield (Greenblatt) % | -17.89 | |||||
FCF Yield % | -9.21 |
GF Valueâ„¢
Patrys Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Patrys Ltd Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Guru Commentaries on OTCPK:PABAF
No articles.
Press Release
Articles on Patrys Ltd
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers